{"altmetric_id":4853731,"selected_quotes":["International #ALS study is recruiting.","New clinical trial run by Biogen in SOD1-ALS. Estimated study start date is Jan 2016.","$ISIS Very Cool - Single and Multiple Dose Study of BIIB067 (Isis-SOD1Rx) in Adults With ALS"],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Biogen"],"first_seen_on":"2015-12-08T19:00:40+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1483993614,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02623699","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02623699?term=isis%20sod1&rank=1","https:\/\/clinicaltrials.gov\/show\/NCT02623699","https:\/\/www.clinicaltrials.gov\/ct2\/show\/study\/NCT02623699?term=sod1&rank=1#contacts"],"nct_id":"NCT02623699","pubdate":"2015-11-24T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Single and Multiple Dose Study of BIIB067 (Isis-SOD1Rx) in Adults With Amyotrophic Lateral Sclerosis (ALS)","type":"clinical_trial_study_record"},"altmetric_score":{"score":14.95,"score_history":{"1y":10,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":14.95},"context_for_score":{"all":{"total_number_of_other_articles":8029393,"mean":6.8051641093086,"rank":538865,"this_scored_higher_than_pct":93,"this_scored_higher_than":7489682,"rank_type":"exact","sample_size":8029393,"percentile":93},"similar_age_3m":{"total_number_of_other_articles":298660,"mean":8.9637460314271,"rank":26900,"this_scored_higher_than_pct":90,"this_scored_higher_than":271712,"rank_type":"exact","sample_size":298660,"percentile":90},"this_journal":{"total_number_of_other_articles":22412,"mean":10.439213957432,"rank":1823,"this_scored_higher_than_pct":91,"this_scored_higher_than":20586,"rank_type":"exact","sample_size":22412,"percentile":91},"similar_age_this_journal_3m":{"total_number_of_other_articles":1039,"mean":16.103146435453,"rank":104,"this_scored_higher_than_pct":89,"this_scored_higher_than":935,"rank_type":"exact","sample_size":1039,"percentile":89}}},"demographics":{"poster_types":{"member_of_the_public":6},"users":{"twitter":{"cohorts":{"Members of the public":6}}},"geo":{"twitter":{"US":4,"CA":1}}},"counts":{"total":{"posts_count":8},"news":{"unique_users_count":1,"unique_users":["alzforum"],"posts_count":1},"twitter":{"unique_users_count":6,"unique_users":["LifeSciGuy","ArtSlott","fedjadee87","rarediseasefdn","Prize4Life","Bodypoint_Inc"],"posts_count":6},"facebook":{"unique_users_count":1,"unique_users":["773526162711684"],"posts_count":1}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/LifeSciGuy\/statuses\/674302314518347777","license":"gnip","citation_ids":[4853731],"posted_on":"2015-12-08T18:59:34+00:00","author":{"name":"LifeSciGuy","image":"https:\/\/pbs.twimg.com\/profile_images\/740560667221069825\/5vQ9p_Vz_normal.jpg","description":"day job: cardiovascular devices... on the side: biotech trader\/investor, author, and tech entrepreneur","id_on_source":"LifeSciGuy","tweeter_id":"340481793","geo":{"lt":null,"ln":null},"followers":1108},"tweet_id":"674302314518347777"},{"url":"http:\/\/twitter.com\/ArtSlott\/statuses\/674405038882750464","license":"gnip","citation_ids":[4853731],"posted_on":"2015-12-09T01:47:45+00:00","author":{"name":"Art","image":"https:\/\/pbs.twimg.com\/profile_images\/748308507460505600\/CwllBuax_normal.jpg","description":"Nature loving, center left, vegetarian, expose quacks, kooks, scammers. Dad fought #NazisInNewark it's a book #Yankees #Giants #Vice, @BillMaher, #biotech $ions","id_on_source":"ArtSlott","tweeter_id":"1545630956","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":1028},"tweet_id":"674405038882750464"},{"url":"http:\/\/twitter.com\/fedjadee87\/statuses\/674524331406442496","license":"gnip","rt":["ArtSlott"],"citation_ids":[4853731],"posted_on":"2015-12-09T09:41:47+00:00","author":{"name":"Vera Adrian","image":"https:\/\/pbs.twimg.com\/profile_images\/604902657602535424\/6NkhKgPI_normal.jpg","id_on_source":"fedjadee87","tweeter_id":"3279060442","geo":{"lt":"45.7874957","ln":"-108.49607","country":"US"},"followers":99},"tweet_id":"674524331406442496"},{"url":"http:\/\/twitter.com\/rarediseasefdn\/statuses\/674637873757315072","license":"gnip","rt":["ArtSlott"],"citation_ids":[4853731],"posted_on":"2015-12-09T17:12:57+00:00","author":{"name":"RareDiseaseFdn","url":"http:\/\/rarediseasefoundation.org","image":"https:\/\/pbs.twimg.com\/profile_images\/842222896156041216\/XwZGlCad_normal.jpg","description":"Changing the lives of patients affected by rare & undiagnosed diseases through social support, advocacy & treatment focused research.\nhttps:\/\/t.co\/pRLOLwRpTO","id_on_source":"rarediseasefdn","tweeter_id":"255195161","geo":{"lt":60.10867,"ln":-113.64258,"country":"CA"},"followers":5717},"tweet_id":"674637873757315072"},{"url":"http:\/\/twitter.com\/Prize4Life\/statuses\/675064164172357632","license":"gnip","citation_ids":[4853731],"posted_on":"2015-12-10T21:26:53+00:00","author":{"name":"Prize4Life","url":"http:\/\/www.Prize4Life.org","image":"https:\/\/pbs.twimg.com\/profile_images\/137862739\/twitter_normal.png","description":"Accelerating the discovery of treatments and a cure for ALS, Lou Gehrig's Disease, using powerful incentives to attract new people and drive innovation.","id_on_source":"Prize4Life","tweeter_id":"31167170","geo":{"lt":37.87159,"ln":-122.27275,"country":"US"},"followers":1551},"tweet_id":"675064164172357632"},{"url":"http:\/\/twitter.com\/Bodypoint_Inc\/statuses\/818554664731803648","license":"gnip","citation_ids":[4853731],"posted_on":"2017-01-09T20:26:54+00:00","author":{"name":"Bodypoint, Inc.","url":"http:\/\/www.bodypoint.com","image":"https:\/\/pbs.twimg.com\/profile_images\/887057785434681345\/hYZp2Gwx_normal.jpg","description":"We manufacture standards-tested supports to improve the safety, comfort and independence of children and adults who use wheelchairs.","id_on_source":"Bodypoint_Inc","tweeter_id":"174777884","geo":{"lt":47.60621,"ln":-122.33207,"country":"US"},"followers":2007},"tweet_id":"818554664731803648"}],"facebook":[{"title":"Single and Multiple Dose Study of BIIB067 (Isis-SOD1Rx) in Adults With Amyotrophic Lateral...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1054825251248439&id=773526162711684","license":"public","citation_ids":[4853731],"posted_on":"2016-02-05T15:23:50+00:00","summary":"Sporadic ALS patients eligible for part A of this study.","author":{"name":"Team DiGiacomo","url":"https:\/\/www.facebook.com\/773526162711684","facebook_wall_name":"Team DiGiacomo","image":"https:\/\/graph.facebook.com\/773526162711684\/picture","id_on_source":"773526162711684"}}],"news":[{"title":"First Round of FTD Therapeutics Fell Short, But Many More Are Up and Running","url":"http:\/\/ct.moreover.com\/?a=28100445561&p=1pl&v=1&x=LHFOLigIsTc833PlbULAzA","license":"public","citation_ids":[8404710,8404709,4696244,12247994,4686343,12247995,4689213,4684736,4686163,5606942,12247996,4685234,4853731,12247997,1655377,3269775,1135591,5433188,5363365,257892,2973198,1333021],"posted_on":"2016-09-27T21:23:51+00:00","summary":"27 Sep 2016 Even as researchers work to unearth the underlying causes of frontotemporal dementia, they are beginning to develop treatments that target specific mechanisms.","author":{"name":"Alzforum","url":"http:\/\/www.alzforum.org","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/355\/normal\/Screen_Shot_2015-04-08_at_12.16.09_1.png?1428491784"}}]}}